<code id='1FFEBD5E9C'></code><style id='1FFEBD5E9C'></style>
    • <acronym id='1FFEBD5E9C'></acronym>
      <center id='1FFEBD5E9C'><center id='1FFEBD5E9C'><tfoot id='1FFEBD5E9C'></tfoot></center><abbr id='1FFEBD5E9C'><dir id='1FFEBD5E9C'><tfoot id='1FFEBD5E9C'></tfoot><noframes id='1FFEBD5E9C'>

    • <optgroup id='1FFEBD5E9C'><strike id='1FFEBD5E9C'><sup id='1FFEBD5E9C'></sup></strike><code id='1FFEBD5E9C'></code></optgroup>
        1. <b id='1FFEBD5E9C'><label id='1FFEBD5E9C'><select id='1FFEBD5E9C'><dt id='1FFEBD5E9C'><span id='1FFEBD5E9C'></span></dt></select></label></b><u id='1FFEBD5E9C'></u>
          <i id='1FFEBD5E9C'><strike id='1FFEBD5E9C'><tt id='1FFEBD5E9C'><pre id='1FFEBD5E9C'></pre></tt></strike></i>

          Home / fashion / hotspot

          hotspot


          hotspot

          author:comprehensive    Page View:5
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In